APPENDIX IV

STATUTORY AND GENERAL INFORMATION

A.

FURTHER INFORMATION ABOUT OUR COMPANY AND OUR SUBSIDIARIES

1.

Incorporation

Our Company was incorporated in the Cayman Islands on October 28, 2010 as an exempted
company with limited liability. Our registered office address is at offices of Mourant Governance
Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman KY1-1108, Cayman
Islands. Accordingly, our Company’s corporate structure and Articles of Association are subject to the
relevant laws of the Cayman Islands. A summary of our Memorandum and Articles of Association is
set out in Appendix III.

Our registered place of business in Hong Kong is at Room 1901, 19/F, Lee Garden One, 33 Hysan
Avenue, Causeway Bay, Hong Kong. We were registered as a non-Hong Kong company under Part 16
of the Companies Ordinance on June 28, 2018 with the Registrar of Companies in Hong Kong. Scott
A. Samuels and Howard Liang have been appointed as the authorised representatives of our Company
for the acceptance of service of process in Hong Kong. The address for service of process is Room
1901, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

As at the date of this prospectus, our Company’s head office was located at No. 30 Science Park
Road, Zhong-Guan-Cun Life Science Park, Changping District, Beijing 102206, People’s Republic of
China.

2.

Changes in share capital of our Company

Our Company was incorporated with an authorized share capital of US$30,000 divided into
300,000,000 shares with a nominal or par value of US$0.0001 each. Upon the listing of our ADSs on
Nasdaq on February 8, 2016, our authorized capital was US$1,000,000 divided into (i) 9,500,000,000
ordinary shares of a par value of US$0.0001 each and (ii) 500,000,000 shares of a par value of
US$0.0001 each.

The following sets out the changes in the Company’s issued share capital during the period

between the listing of our ADSs on Nasdaq and the date of this prospectus:

(a) On November 23, 2016, the Company completed a follow-on public offering and sold
5,781,250 ADSs representing 75,156,250 Shares. Additionally, the underwriters exercised
their option to purchase an additional 850,000 ADSs representing 11,050,000 Shares from
our Company. The selling shareholders sold 468,750 ADSs representing 6,093,750 Shares;
and

(b) On August 16, 2017,

the Company completed a follow-on public offering and sold
2,465,000 ADSs representing 32,045,000 Shares. Additionally, the underwriters exercised
their option to purchase an additional 369,750 ADSs representing 4,806,750 Shares from
the Company.

— IV-1 —

